Abstract Preventing Pseudomonas syringae pv. actinidiae (Psa), the causal agent of bacterial canker of kiwifruit, from entering pruning wounds would reduce disease incidence and facilitate canopy management. Antibacterial activity against Psa has been determined in the laboratory for active ingredients commercially available in New Zealand. Only tebuconazole, tebuconazole with octhilinone and a formulation of cyproconazole and iodocarb killed Psa on agar plates or in liquid medium. However, only tebuconazole with octhilinone killed Psa within 5 min. Psa was detected by polymerase chain reaction following plating on instruments used for applying wound protectants in an infected orchard. This suggests that under some conditions the pathogen could be transferred from vine to vine when applying some wound protectants. Addition of streptomycin sulphate to tebuconazole or a formulation of cyproconazole and iodocarb did not result in a rapid and complete kill of Psa similar to that with a commercial formulation of streptomycin applied alone.
INTRODUCTION
Pseudomonas syringae pv. actinidiae (Psa), the causal agent of bacterial canker of kiwifruit, has recently spread to most of the major kiwifruitproducing countries around the world (Vanneste 2013) . In New Zealand, this pathogen has been isolated from commercial orchards of Actinidia deliciosa (green-fleshed kiwifruit), A. chinensis (yellow-fleshed kiwifruit) and A. arguta (kiwiberry) (Everett et al. 2011; Vanneste et al. 2013; Vanneste et al. 2014) . While Psa threatened the economic viability of growing A. chinensis and A. deliciosa in New Zealand (Vanneste 2012) , it had no real economic impact on A. arguta (Vanneste et al. 2014) . Bacterial pathogens isolated in New Zealand from symptomatic kiwifruit plants were initially grouped into two biovars: biovar 3 and biovar 4 ). However, recently it has been demonstrated that strains of biovar 4 belong to a distinct pathovar now called Pseudomonas syringae pv. actinidifoliorum (Cunty et al. 2014) . Therefore at present, all Psa strains isolated from New Zealand belong to biovar 3 .
Most Actinidia species are dioecious, with separate male and female plants. Both male and female kiwifruit plants need to be pruned several times during the year. In winter, pruning is needed to remove dead or unproductive wood. In summer, pruning of female vines is needed to remove unnecessary shoots and to keep replacement canes to a manageable length. On male vines, the canes that have flowered are removed in early summer once the fruit has set on the female vines. All these pruning wounds could potentially be entry points into the plant for Psa, as is the case for other pathovars of P. syringae (Kennelly et al. 2007) .
A number of products have been developed over the years to protect pruning wounds of kiwifruit and other plants. These woundprotectant products form a physical barrier that prevents potential pathogens from getting inside the plants. Some of these products also contain one or more active ingredients, which may kill some pathogens. Although most of these products have been developed to prevent fungal infection, the aim of this study was to determine whether any of these products could inhibit or kill Psa in vitro. Wound protectants that killed Psa could be used after pruning or grafting when conditions are favourable for infection, reducing disease incidence and facilitating canopy management. The survival of Psa in the products or on the tools used to apply the products in an infected orchard was also examined. This was to determine whether protecting wounds with any of these products could also result in spreading the pathogen in the orchard.
MATERIALS AND METHODS

Strain and media
All the laboratory experiments were conducted in the Physical Containment level 2 (PC2) laboratory of The New Zealand Institute for Plant & Food Research Ltd at the Ruakura Research Centre. The bacterial strain used in these experiments was Psa10627, a strain of biovar 3 isolated in New Zealand in 2010 . Psa was routinely cultivated on King's B medium (KB) (King et al. 1954) . Bacterial concentration was determined by plating serial dilutions made in sterile distilled water on KB agar plates after 48 h of incubation at 28°C. When a complete growing medium was required, Luria (Invitrogen Life Technologies Ltd) was used. When necessary, Psa identity was confirmed by polymerase chain reaction (PCR) using the primers Psa F1/Psa R2 (Rees-George et al. 2010) as described previously .
Wound protectants
The wound protectant formulations used in this project and their characteristics are listed in Table 1 . Streptomycin sulphate and KeyStrepto™, a commercial product that contains streptomycin sulphate, are the only two products that are not sold as wound protectants. They were used as positive controls or possible adjuvants to the other products. Of the six other products, five are still commercially available. Garrison NF, which was used in the initial experiments, is no longer available; it has been replaced by Garrison Rapid. Although Garrison NF and Garrison Rapid contain the same active ingredients at the same concentration, they are different colours and gave different results, so they have been treated as two different products. These commercial products are sold to protect pruning wounds. However, Gripset Betta is also widely used in the building industry as a waterproof coating.
Inhibition of Psa on agar plate and in water
Inhibition of Psa on plates was detected by spotting a 10-µl drop of the product to be tested on a soft agar overlay seeded with Psa10627 at ca 5×10 7 cfu/ ml. The experiment was conducted on KB and Luria agar plates, with three plates of each medium used per product. All the products except the wax were tested. Presence of a zone of inhibition was detected after 48 h of incubation at 28°C. Water and 10-ppm streptomycin were used on every plate as a negative and a positive control respectively.
To prevent possible interactions between the product and components of the medium in which Psa had grown, inhibition of Psa in liquid was done in water. A bacterial suspension made in water from a fresh plate was mixed with the same volume of the product to be tested. Except when otherwise mentioned, the final solution was a 50/50 (vol/vol) aqueous solution of the product to be tested. After a given incubation time, the population of Psa that survived the treatment was determined by plating 1/10 serial dilutions made in sterile distilled water on KB agar plates and counting the colonies that had grown 48 h after incubation at 28°C. Determination of the Minimum Inhibitory Concentration (MIC) was carried out in water as described above, using decreasing concentrations of the product to be tested.
Survival and potential transferability of Psa in the orchard
The commercial formulations of tebuconazole, tebuconazole with octhilinone, cyproconazole with iodocarb (formulation 1), wax and bitumen were applied on kiwifruit stumps in August 2012 during the grafting of A. chinensis 'Zesy002' (commonly known as Gold3) in an infected orchard in Te Puke, Bay of Plenty, New Zealand. Five samples of each product were used, and for each sample a new application tool was employed. All products except the wax were applied with a small paintbrush. Each brush was used four times; each time, it was dipped into one sample of product and swiped at least twice over the cut area of a grafted stump. The wax was applied with a kitchen butter knife on four stumps. The tools were then individually placed in plastic bags, the product samples were sealed, and all were sent to the PC2 Plant & Food Research laboratory at Ruakura. One sample of each product and one tool were analysed on the day of use, whereas the others were analysed the following day.
Presence of Psa on the tools or in the product samples was determined by PCR following plating. For the product samples (except for the wax, which could not be diluted in water), 2.5 ml of products were mixed with an equal volume of water and 500 µl was spread onto KB plates. For the wax, 2 ml of sterile water was deposited on the top of the samples and mixed as thoroughly as possible before spreading 500 µl onto KB plates. The brushes were washed in 5 ml of water and 500 µl was spread onto KB plates. The knives were cleaned with cotton swabs, which were then washed in 2 ml of water; 500 µl of the washing was spread onto a KB plate. After incubation at 28°C for 24 h, a swipe with a pipette tip was made across the plate and used to inoculate a PCR tube containing the primers PsaF1/R2. The PCR was carried out as described previously .
RESULTS
Inhibition of Psa on agar plates
Cyproconazole with iodocarb (formulation 1) and the bitumen did not inhibit the growth of Psa on either KB or Luria agar plates. Tebuconazole, tebuconazole with octhilinone and cyproconazole with iodocarb (formulation 2) inhibited the growth of Psa on KB medium and on Luria plates (Table  2) . These three formulations produced a single clear zone of inhibition on both media. In contrast, streptomycin sulphate produced two zones of inhibition -a small clear one and a larger opaque one. On KB, only tebuconazole with octhilinone produced a zone of inhibition larger than the clear zone of inhibition obtained with streptomycin sulphate at 10 ppm. On Luria, both tebuconazole with octhilinone and cyproconazole with iodocarb (formulation 2) produced a zone of inhibition larger than the clear zone of inhibition produced by streptomycin sulphate 10 ppm.
Inhibition of Psa in liquid medium
When a suspension of Psa containing 7.7×10 9 cfu/ml was mixed in a 50% (vol/vol) aqueous solution of the different formulations, tebuconazole with octhilinone killed Psa within 5 min (data not shown) and tebuconazole killed Psa within 30 min (Table 3) . However, tebuconazole did not always kill Psa within 30 min; a minimum 3-h incubation time was necessary to kill Psa consistently (data not shown). Cyproconazole with iodocarb (formulation 2) killed Psa within 24 h (Table 4 ). The other formulations: cyproconazole with iodocarb (formulation 1), the bitumen and the wax, did not kill Psa even after 24 h of incubation. However, the bitumen reduced the population of Psa from 7.7×10 9 to 6.0×10 6 cfu/ml (Table 4) , and in at least one experiment, cyproconazole with iodocarb (formulation 1) reduced the Psa population from 10 9 to 10 8 cfu/ml after 24 h. The MIC when using ca 2×10 7 cfu/ml was 1% for the formulation of tebuconazole with octhilinone after 1 h exposure and was 40% after 3 h exposure for the formulation of tebuconazole (Table 5 ). The MIC for cyproconazole with iodocarb (formulation 2) was determined after 24 h incubation and was 1%. The time of exposure was different for each of the formulations since the products required different times to kill Psa.
Survival and potential transferability of Psa in the orchard
Psa was found in two of the five samples of wax, but was not found in any of the other product samples used in the orchard (Table 6 ). Psa was found on brushes used to spread all the products except tebuconazole with octhilinone (Table 6 ). Of the eight samples in which Psa was detected, six had been plated the day after use in the orchard.
Effect of streptomycin as an adjuvant to wound protectants While streptomycin at 100 ppm, provided as streptomycin sulphate or as a commercial formulation of streptomycin, killed Psa in a liquid containing ca 10 7 cfu/ml within 15 min, addition of streptomycin at the same concentration to a 50% (vol/vol) solution containing tebuconazole or cyproconazole with iodocarb formulation 1 or formulation 2 did not result in a complete kill of Psa within 30 min for tebuconazole, 1 h for cyproconazole with iodocarb (formulation 2), or even within 24 h for cyproconazole with iodocarb (formulation 1) ( Table 7) .
DISCUSSION
Very few studies have looked at the impact of pruning on incidence of bacterial diseases and even fewer have looked at how to reduce that impact using commercially available wound protectants. One exception is a study on sweet cherry, which concluded that copper or phosphite had a very limited or no effect on incidence of bacterial canker caused by P. syringae pv. syringae (Carroll et al. 2010) . One of the reasons for this very limited number of studies might be that most wound protectants were developed for protection against fungal pathogens.
Of the products commercially available in New Zealand, three formulations -tebuconazole, tebuconazole with octhilinone and cyproconazole with iodocarb (formulation 2) -inhibited Psa on agar plates. The inhibition as measured by the diameter of the zone of inhibition was in some cases stronger than that given by streptomycin sulphate at 10 ppm. However, while the wound protectants were deposited undiluted on the bacterial overlay, streptomycin sulphate at 10 ppm is only 1/10 of the recommended rate for streptomycin.
Only tebuconazole with octhilinone killed Psa in liquid medium in less than 5 min. In some cases, tebuconazole killed Psa in 30 min, but this was not consistent and the reason for this variability is not known. However, by increasing the time of contact between the pathogen and the product to 3 h, the bacteria were consistently killed. Although the products had to be diluted to determine their ability to kill or inhibit Psa, the MIC of the three products that killed Psa was well below the 50% vol/vol rate at which the experiments were conducted.
Because the products that killed Psa required a long period of contact with the bacteria to kill them, the possibility that using those products in the orchard might help to spread the pathogen was investigated. Psa was found surviving in two of the five samples of wax used to treat infected stumps, but was not found in any of the other product samples used in the same orchard (Table 6 ). It might be that by analysing a larger number of product samples, or using each sample for more than four stumps, Psa would have been found in the products that have shown to be unable to kill or inhibit Psa in vitro. Psa was found on the brushes used to spread all the products except the formulation of tebuconazole with octhilinone (Table 6 ). This is not surprising, given that this product was shown to kill Psa at very low concentrations and in a very short time. Psa was found most often on the bitumen, which did not kill Psa in the laboratory.
To determine whether addition of streptomycin to products that did not kill Psa, or needed a long contact time to kill it, could prevent the spread of the pathogen via orchard tools, the survival of Psa in water supplemented with a wound protectant and streptomycin (100 ppm) was determined. The addition of streptomycin sulphate or a commercial formulation of streptomycin sulphate to cyproconazole with iodocarb (formulation 1) did not result in a complete kill of Psa within 24 h. Addition of a commercial formulation of streptomycin sulphate to tebuconazole or cyproconazole with iodocarb (formulation 2) reduced the Psa population after 30 min and 1 h respectively, while the commercial formulation of streptomycin sulphate by itself killed Psa with 15 min (Table 7) . These results indicate that these three products somehow interfere with the ability of streptomycin sulphate to kill Psa. Similar results have been reported for tebuconazole using lower concentrations of streptomycin (10 ppm) ).
In conclusion, of the wound protectant formulations commercially available in New Zealand only tebuconazole with octhilinone showed some strong antibacterial activity. The main advantage of the other compounds might be in physically preventing the pathogen from entering the plant, rather than killing the pathogen. However, since Psa can survive in some of those compounds or on the tools used to apply them, there might be a risk of distributing the pathogen onto non-infected plants, when using them in an infected orchard. Addition of a strong bactericidal compound, such as streptomycin, did not result in a rapid and complete kill of Psa and therefore would not prevent the spread of the pathogen in an infected orchard when using those products.
